Recall Z-0938-2026
Instrumentation Laboratory · initiated November 18, 2025
Class III – products unlikely to cause any adverse health reaction but that violate FDA labeling or manufacturing laws
Product
HemosIL SynthAFax. Partial Thromboplastin Time Tests.
Codes / lots: Part No. 0020007400; UDI: 08426950087649; Lot No. (Exp. Date) N0542231(2026-06-30), N0250088(2027-04-30, N0452249 (2027-06-30).
Reason for recall
Recalled lots were manufactured with double the amount of preservative concentration.
FDA-determined cause: Process control
Action taken
An URGENT MEDICAL DEVICE RECALL notification, dated 11/18/25, was sent to consignees. Consignees are to contact Client Services at 1-800-955-9525 to arrange conversion to replacement lot N0956748, and in the meantime continue use of affected lots with the QC lot reassignments provided and run QC per labeled instructions for use. Once the replacement lot is received, consignees are to complete the cross-over study per laboratory procedures and immediately destroy affected devices, documenting destruction on the provided Mandatory Urgent Medical Device Recall Tracking Form which should be returned to WERFEN by fax at 781-861-4207 or by email to ra-usa.na@werfen.com. All laboratory staff are to be notified of this recall and a copy of the notice posted near IL Coagulation Systems. Consignees with any questions are to contact Client Services at 1-800-955-9525.
Details
- Recall number
- Z-0938-2026
- Initiated
- November 18, 2025
- Posted by FDA
- December 17, 2025
- Product code
- GFO – Activated Partial Thromboplastin
- Quantity
- 4,506 units
- Distribution
- Domestic: CA, CO, FL, NY; Foreign: AR, AT, CA, CZ, DE, DK, ES, FR, GB, IE, IL, IN, IT, JP, LK, NL, PL, PT, RO, RS, TH, VN.
- Recalling firm
- Instrumentation Laboratory, Bedford, MA